Latest current cash for ALIM: $11M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Alimera Sciences (ALIM) currently reports a current cash of $11M as of June 2024. That compares with $19M in the prior-year period — down 42.2% year over year. Use the charts on this page to explore Alimera Sciences's current cash history and peer comparisons.
Alimera Sciences's current cash decreased from $19M to $11M — a 42.2% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Alimera Sciences reported $11M in current cash as of June 2024. That compares with $19M in the prior-year period — down 42.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alimera Sciences, and consider following ALIM for alerts when major investors trade the stock.
Alimera Sciences is classified in the Healthcare sector. On current cash, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALIM with unrelated industries.